Information  X 
Enter a valid email address

Santander UK Plc (65WK)

  Print   

Friday 21 January, 2022

Santander UK Plc

1195 LSE Cancellation Announcement

RNS Number : 2628Z
Santander UK Plc
21 January 2022
 

NOTICE OF CANCELLATION

Santander UK plc (the "Issuer")

£20,000,000 Equity Index Linked Notes due January 2028

XS2403519783 

(the "N&C Securities")

This notice relates to the abovementioned N&C Securities issued by the Issuer under the base prospectus relating to its Notes and Certificates Programme dated 4 October 2021 (the "Base Prospectus") and the final terms relating to the N&C Securities dated 8 November 2021 (the "Final Terms"). 

Notice is hereby given that following the end of the Offer Period (as defined in the Final Terms) relating to the N&C Securities the Issuer will cancel the N&C Securities in a principal amount of £19,017,723 with immediate effect and that consequently following such cancellation the aggregate principal amount of the N&C Securities which remains outstanding will be reduced to £982,277 .


For further information, please contact:

Structured Notes Desk

Tel: +44 (0) 20 7756 7000 or [email protected] .

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Base Prospectus and Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus and/or the Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus and/or the Final Terms is not addressed. Prior to relying on the information contained in this notice, the Base Prospectus and/or the Final Terms, you must ascertain from the Base Prospectus and/or the Final Terms whether or not you are part of the intended addressees of the information contained therein.

Your right to access this service is conditional upon complying with the above requirement.

Neither the Base Prospectus nor the Final Terms referenced herein constitutes an offer of securities for sale in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America, except pursuant to an exemption from the Securities Act.

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCBBMJTMTMTBPT

a d v e r t i s e m e n t